 |
Business update:
|
|
Program Agenda
|
DAY I: Wednesday, November 16, 2011 |
|
|
8:00 AM |
Meeting Registration Open |
|
9:00 AM |
Introduction: Dr. Mahadev Murthy Program Director NIH, Bethesda, USA Inauguration |
|
|
Welcome address |
|
9:30 AM |
KEYNOTE TALK Prasad Devarajan, M.D., Louise M. Williams Endowed Chair, Professor of Pediatrics and Developmental Biology, Director of Nephrology and Hypertension, Director, Clinical Nephrology Laboratories, CEO, Dialysis Unit, Cincinnati Children's Hospital Medical Center University of Cincinnati College of Medicine, Cincinnati, OH Renal Markers: Clinical and Toxicological Perspectives. |
|
10:15 AM |
COFFEE BREAK |
|
10:30 AM |
CANCER BIOMARKERS SESSION 1- DIAGNOSIS, THERAPEUTICS AND THERAPY |
|
|
Chair: Yuri Nikolsky; Co-Chair: Daya Upadhyay Yuri Nikolsky, Ph.D., M.B.A., Vice President, R&D, Healthcare & Science, Thomson Reuters, Genego, San Diego, CA, Functional Synergy Analysis of OMICs Data of Different Types in Cancer Research Daya Upadhyay, M. D., Pulmonary and Critical Care Medicine, Stanford School of Medicine, Stanford, USA; 'Circulating microRNAs as Novel Targets in Lung Cancer: Clinical Significance in Lung Cancer Development and Management' Adhip P. N. Majumdar, Ph. D. Wayne State University School of Medicine, USA; Cancer Stem Cells Markers: Implications for the Age-related Rise in Colorectal Cancer Uma Prabhakar, Ph.D., Alliance for Nanotechnology in Cancer, Office of the National Cancer Institute, Bethesda, USA
Biomarkers in Clinical Development:
The Pharmacological Audit Trail approach |
|
12:30 PM |
LUNCH BREAK |
|
2:00 PM |
SESSION 2-PROGNOSTIC CANCER BIOMARKERS Dipak Banerjee, Ph. D., Professor, Department of Biochemistry, School of Medicine and Member, Institute of Functional Nanomaterials, University of Puerto Rico, Medical Sciences Campus, San Juan, ]USA Mannosylphospho dolichol synthase: A novel biomarker for aging to congenital disorder to breast cancer prognosis. Suniti Misra, Ph.D. Medical University of South Carolina, USA
CD44v6, a novel biomarker and
target for anti-angiogenic and anti-cancer therapy for colon
rectal carcinogenesis Prostate Cancer Biomarkers for Molecular Targeted Therapy and Optimized Treatment Selection: Designing Customized Laboratory Tools in the Era of Personalized Medicine |
|
3:30 PM |
COFFEE BREAK |
|
4:00 PM |
SESSION 3- DISEASE BASED MARKERS Jackson Streeter, M. D., C.E.O., Banyan Biomarkers, Alachua, USA Traumatic Brain Injury Biomarkers: Bench to Bedside Haris Jamil, Ph.D., Vice President, NanoInk Inc., Skokie, USA Miniaturized Biomarker Assays in Complex Biological Samples for Drug Discovery and Clinical Trials Dr. Lekha Dinesh Kumar, Ph. D., Principal Scientist, E112, Project Leader, Cancer Biology, Centre for Cellular & Molecular Biology, Hyderabad, AP, India MicroRNAs in breast cancer and Acute lymphoblastic leukemia |
|
5:30 PM |
ADJOURN |
|
DAY II: Thursday, November 17, 2011. |
|
|
9:00 AM |
MOLECULAR IMAGING IN DIAGNOSTICS AND THERAPEUTICS Chair: Pushpa Tandon, Co-Chair: Dr. Rao V. L. Papineni |
|
|
KEYNOTE TALK Samuel Achilefu, Ph.D., Professor of Radiology, Biochemistry & Molecular Biophysics, and Biomedical Engineering; Chief, Optical Radiology Laboratory, Washington University School of Medicine, St. Louis, USA Serendipity in molecular optical imaging of cancer |
|
9:45 AM |
Tayyaba Hasan, Ph. D. Professor, Wellman Center for Photomedicine, Harvard Medical School, Massachusetts General Hospital, Boston, USA Optical strategies for monitoring biomarkers in vivo for treatment design Pankaj Chaturvedi, MS, FAIS, FICS, FACS, MNAMS, Associate Professor, Head and Neck Department, TATA Memorial Hospital, Mumbai, India “In Vivo Non-invasive diagnosis of oral lesions: Are we ready to go to the community?” |
|
10:45 AM |
COFFEE BREAK |
|
11:00 AM |
NEW STRATEGIES AND DIRECTIONS Ali Azhdarinia, Ph.D. Assistant Professor, Institute of Molecular Medicine-Center for Molecular Imaging, Houston, USA. “Dual-labeling Strategies for Combined Near-infrared/Nuclear imaging of biomarkers in cancer” Pushpa Tandon, Ph.D., Program Director, Cancer Imaging Program, National Cancer Institute, Bethesda, USA New Directions for Imaging as an enabling technology for Diagnosis & Therapeutics |
|
12:30 PM |
LUNCH BREAK |
|
2:00 PM |
KEYNOTE TALK Vinod Marathe, M. B. B. S., D. M. R.D., M. D. (Radiology), FIIM, D. Sc., Ph. D. Pravar Institute of Medical Sciences, Loni, India; Evidence-based Translation research in Vascular Blocks |
|
2:45 PM |
Devendra Parmar, Ph.D., Indian Institute of Toxicological Research, Lucknow, India. Cytochrome P450s: A biomarker for predicting chemical exposure, effect and susceptibility |
|
3:30 PM |
COFFEE BREAK |
|
4:00 PM |
Jamie Barger, LifeGen Technologies LLC; Madison, Wisconsin, USA Transcriptional biomarkers of calorie restriction in adipose tissue and modulation by dietary interventions Panel Discussion: Panelists - Pushpa Tandon, Samuel Achilefu, Tayyaba Hasan, Pankaj Chaturvedi, Ali Azhdarinia, Vinod Marathe, Devendra Parmar, Mahadev Murthy |
|
6:30 PM |
Dinner Speaker: Dr. Rao V. L. Papineni, Ph.D., Distinguished Scientist, Senior Principal Investigator, Carestream Health, Inc., Woodbridge, USA CARESTREAM MOLEULAR IMAGING DINNER BANQUET |
|
DAY III: Friday, November 18, 2011 |
|
|
|
INDUSTRY AND HEALTHCARE PERSPECTIVES |
|
9:00 AM |
KEYNOTE TALK Peter Barker, Ph. D., Virginia, USA Cancer Biomarkers |
|
9:45 AM |
Sandeep Saxena, Founder and
CEO, Acton Biotech (India) Pvt. Ltd. Emerging trends in bio marker usage in India Uma Prabhakar, Ph.D., Alliance for Nanotechnology in Cancer, National Cancer Institute, Bethesda, USA Biomarkers and Healthcare: Industry perspectives |
|
10:30 AM |
COFFEE BREAK |
|
10:45 AM |
THINK TANK SESSION Prospects and Challenges Associated Translational Biomarkers Therapeutics and Diagnostics Panel Discussion Panelists - Gundu Rao, Yuri Nikolsky, Haris Jamil, Jamie Barger, Alex J. Rai, Pushpa Tandon, Uma Prabhakar, Mahadev Murthy |
|
1:00 PM |
LUNCH |
|
2:00 PM |
Panel discussion and Recommendations |
|
4:00 PM |
Closing Remarks and Adjourn |
Sponsors
